PROTARA

Serial Number 98182801
688

Registration Progress

Application Filed
Sep 15, 2023
Under Examination
Apr 29, 2025
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Oct 29, 2025 112 days

Basic Information

Serial Number
98182801
Deadline
October 29, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
September 15, 2023
Published for Opposition
March 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Apr 29, 2025
Application
Pending
Classes
005 044

Rights Holder

Protara Therapeutics, Inc.

03
Address
345 Park Avenue South, 3rd Floor
New York, NY 10010

Ownership History

Protara Therapeutics, Inc.

Original Applicant
03
New York, NY

Protara Therapeutics, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

Next Deadline
112 days remaining
NOA E-Mailed - SOU Required
Due Date
October 29, 2025
Extension Available
Until April 29, 2026

Application History

17 events
Date Code Type Description
Apr 29, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2025 DOCK D ASSIGNED TO EXAMINER
Nov 8, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 8, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 9, 2024 DOCK D ASSIGNED TO EXAMINER
May 9, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2024 CNRT R NON-FINAL ACTION WRITTEN
May 9, 2024 GNRT F NON-FINAL ACTION E-MAILED
Oct 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical and biological preparations for the treatment of bladder cancer; Pharmaceutical and biological preparations for the treatment of intestinal failure associated liver disease and other diseases and deficiencies, namely, as a source of choline for patients on parenteral nutrition who are otherwise unable to meet their choline needs via oral or enteral routes; Pharmaceutical and biological preparations for the treatment of maxillofacial cysts and other cavernous malformations, namely, lymphatic malformations; Pharmaceutical and biological preparations for the treatment of proliferative diseases
Class 044
Providing information regarding diseases and disorders via a website; Providing information regarding pharmaceutical and biological preparations via a website

Classification

International Classes
005 044